Literature DB >> 8106808

Psychological distress in patients attending an oncology clinic after definitive treatment for maxillofacial malignant neoplasia.

M R Telfer1, J P Shepherd.   

Abstract

Although management of malignant tumours of the mouth and salivary glands generally involves joint consultation with radiotherapists in dedicated oncology clinics, patients' preferences or psychological needs in this environment have not been investigated prospectively, particularly for those on long-term review after treatment. In this prospective study, therefore, psychometric data were collected from a series of 40 consecutive review patients by questionnaires completed on the day of consultation. The following established psychometric tests were used: the Hospital Anxiety and Depression Scale and the General Health Questionnaire. Patients' reactions to duration of consultation, advice given, opportunity to ask questions, and number of staff present were also investigated by a standard structured questionnaire. Forty-seven per cent of patients exhibited symptoms of psychiatric disturbance; 33% were anxious, and 15% were depressed, preoccupation with physical symptoms being the most frequent problem. Explanations of continuing physical symptoms were particularly highly valued because these were often wrongly interpreted by the patients as evidence of recurrence. No patient objected to the presence of students and only one to the presence of more than 10 members of staff. However, 18% requested one-to-one discussion in addition.

Entities:  

Mesh:

Year:  1993        PMID: 8106808     DOI: 10.1016/s0901-5027(05)80664-2

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  7 in total

1.  Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: implications for clinical practice.

Authors:  Hellie Lithoxopoulou; Konstantinos Zarogoulidis; Sevasti Bostantzopoulou; Ellada Eleftheriadou; Paul Zarogoulidis; Haidong Huang; Konstantinos Porpodis; Ioannis Kioumis; Theodora Tsiouda; Lonny Yarmus; Theodore Kontakiotis
Journal:  Support Care Cancer       Date:  2014-03-22       Impact factor: 3.603

2.  Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia.

Authors:  Susan Reisine; Douglas E Morse; Walter J Psoter; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai
Journal:  J Oral Maxillofac Surg       Date:  2005-04       Impact factor: 1.895

3.  Enhanced patient reported outcome measurement suitable for head and neck cancer follow-up clinics.

Authors:  Naseem Ghazali; Derek Lowe; Simon N Rogers
Journal:  Head Neck Oncol       Date:  2012-06-13

4.  Multiattribute utility assessment of outcomes of treatment for head and neck cancer.

Authors:  S C Hodder; M J Edwards; M R Brickley; J P Shepherd
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Anti-HER-2 DNA vaccine protects Syrian hamsters against squamous cell carcinomas.

Authors:  G N Berta; B Mognetti; M Spadaro; E Trione; A Amici; G Forni; F Di Carlo; F Cavallo
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640

6.  The Hospital Anxiety And Depression Scale.

Authors:  R Philip Snaith
Journal:  Health Qual Life Outcomes       Date:  2003-08-01       Impact factor: 3.186

7.  Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma.

Authors:  Soheil Pardis; Yasaman Sardari; Mohammad Javad Ashraf; Azadeh Andisheh Tadbir; Hooman Ebrahimi; Sara Purshahidi; Bijan Khademi; Mohammad Javad Fattahi; Marzieh Hamzavi
Journal:  Iran J Otorhinolaryngol       Date:  2012
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.